Literature DB >> 21430947

Re: novel influenza A (H1N1) virus infection in children: chest radiographic and CT evaluation.

Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21430947      PMCID: PMC3052621          DOI: 10.3348/kjr.2011.12.2.266

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


× No keyword cloud information.
Dear Editor: I read the recent publication on pediatric novel influenza A (H1N1) virus infection imaging with a great interest (1). Choi et al. (1) concluded that abnormal imaging was uncommon and prominent peribronchial markings and ill-defined patchy consolidation with mediastinal lymph node enlargement, pleural effusion and pneumomediastinum are the important findings. I would like to share some ideas in this report. Indeed, the low prevalence of lung abnormalities is not surprising since the nature of the novel H1N1 influenza is the upper, not lower, respiratory tract infection (2). Focusing on the described manifestations, there is no specific presentation and so these findings can help make the differential diagnosis of several other lung diseases, as Choi et al. (1) noted. A recent interesting publication noted the occurrence "bilateral extensive air-space disease in severely ill patients" and this might be used as the predictor of the disease severity (3).
  3 in total

1.  Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection.

Authors:  Prachi P Agarwal; Sandro Cinti; Ella A Kazerooni
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

2.  Swine flu: the present pandemic infectious disease.

Authors:  Viroj Wiwanitkit
Journal:  Kulak Burun Bogaz Ihtis Derg       Date:  2009 Mar-Apr

3.  Novel influenza A (H1N1) virus infection in children: chest radiographic and CT evaluation.

Authors:  Min Jeong Choi; Young Seok Lee; Jee Young Lee; Kun Song Lee
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.